Abiopharma

DEFA14A (Additional Proxy Soliciting Materials (definitive)) SEC Filing

BioLife Solutions Unveils the Aby J. Mathew Center for Biopreservation Excellence

8-K (Current report filing) SEC Filing

Elanco Animal Health Inc. - Elanco to Participate in the Upcoming Investor Conferences

Edgewise Therapeutics - Edgewise Therapeutics Appoints Commercial Biotech Executive Christopher Martin to its Board of Directors

Shattuck Labs - Shattuck Labs to Participate in Upcoming December Investor Conferences

Quantum-Si Highlights Significant Development Advancements forProteus™ and Industry Leading Technology Pipeline at Investor & Analyst Day

Clene to Participate at the Benchmark 14th Annual Discovery One-on-One Investor Conference

Ensysce Biosciences Receives Positive FDA Feedback on PF614 Manufacturing Approach

Shattuck Labs to Participate in Upcoming December Investor Conferences